Drug intelligence / Profile preview

hydrocortisone tertiary-butylacetate

Development stage: Unknown
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration: Intraarticular

Overview

Hydrocortisone tertiary-butylacetate is a synthetic ester derivative of hydrocortisone, a naturally occurring glucocorticoid hormone. It has been investigated for intra-articular therapy in rheumatic diseases, where it acts as an anti-inflammatory and immunosuppressive agent. Like other corticosteroids, its mechanism of action involves binding to the glucocorticoid receptor and modulating gene expression to suppress inflammation and immune responses. Hydrocortisone derivatives are commonly used for their ability to reduce swelling, redness, and immune activity in various inflammatory conditions[3].

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on hydrocortisone tertiary-butylacetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone tertiary-butylacetate.

Explore the full profile